Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexandra J Livingstone"'
Autor:
David M Kranz, Michael J White, Mao Li, Maximilian O Schaettler, Rupen Desai, Anthony Z Wang, Alexandra J Livingstone, Dale K Kobayashi, Andrew T Coxon, Jay A Bowman-Kirigin, Connor J Liu, Diane E Bender, Tanner M Johanns, Gavin P Dunn
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background Adoptive cellular therapies with chimeric antigen receptor T cells have revolutionized the treatment of some malignancies but have shown limited efficacy in solid tumors such as glioblastoma and face a scarcity of safe therapeutic targets.
Externí odkaz:
https://doaj.org/article/67ba15afade74b8a9caa7534c5ef5ce0
Autor:
Jay A. Bowman-Kirigin, Rupen Desai, Brian T. Saunders, Anthony Z. Wang, Maximilian O. Schaettler, Connor J. Liu, Alexandra J. Livingstone, Dale K. Kobayashi, Vivek Durai, Nicole M. Kretzer, Gregory J. Zipfel, Eric C. Leuthardt, Joshua W. Osbun, Michael R. Chicoine, Albert H. Kim, Kenneth M. Murphy, Tanner M. Johanns, Bernd H. Zinselmeyer, Gavin P. Dunn
Publikováno v:
Cancer Immunology Research. 11:20-37
The central nervous system (CNS) antigen-presenting cell (APC) that primes antitumor CD8+ T-cell responses remains undefined. Elsewhere in the body, the conventional dendritic cell 1 (cDC1) performs this role. However, steady-state brain parenchyma c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b58cb33b1a59b76b274c7a4bec8ecf1
https://doi.org/10.1158/2326-6066.cir-22-0098
https://doi.org/10.1158/2326-6066.cir-22-0098
Autor:
Gavin P. Dunn, Bernd H. Zinselmeyer, Tanner M. Johanns, Kenneth M. Murphy, Albert H. Kim, Michael R. Chicoine, Joshua W. Osbun, Eric C. Leuthardt, Gregory J. Zipfel, Nicole M. Kretzer, Vivek Durai, Dale K. Kobayashi, Alexandra J. Livingstone, Connor J. Liu, Maximilian O. Schaettler, Anthony Z. Wang, Brian T. Saunders, Rupen Desai, Jay A. Bowman-Kirigin
Supplementary Figures and Tables.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ee81d152485914d2570e049914be76
https://doi.org/10.1158/2326-6066.22546134.v1
https://doi.org/10.1158/2326-6066.22546134.v1
Autor:
Gavin P. Dunn, Bernd H. Zinselmeyer, Tanner M. Johanns, Kenneth M. Murphy, Albert H. Kim, Michael R. Chicoine, Joshua W. Osbun, Eric C. Leuthardt, Gregory J. Zipfel, Nicole M. Kretzer, Vivek Durai, Dale K. Kobayashi, Alexandra J. Livingstone, Connor J. Liu, Maximilian O. Schaettler, Anthony Z. Wang, Brian T. Saunders, Rupen Desai, Jay A. Bowman-Kirigin
The central nervous system (CNS) antigen-presenting cell (APC) that primes antitumor CD8+ T-cell responses remains undefined. Elsewhere in the body, the conventional dendritic cell 1 (cDC1) performs this role. However, steady-state brain parenchyma c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb45f311006488389e8bbe0e0d51222
https://doi.org/10.1158/2326-6066.c.6551106
https://doi.org/10.1158/2326-6066.c.6551106
Autor:
Maximilian O Schaettler, Rupen Desai, Anthony Z Wang, Alexandra J Livingstone, Dale K Kobayashi, Andrew T Coxon, Jay A Bowman-Kirigin, Connor J Liu, Mao Li, Diane E Bender, Michael J White, David M Kranz, Tanner M Johanns, Gavin P Dunn
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006121
BackgroundAdoptive cellular therapies with chimeric antigen receptor T cells have revolutionized the treatment of some malignancies but have shown limited efficacy in solid tumors such as glioblastoma and face a scarcity of safe therapeutic targets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5ed32802689afcf971397681ace5ef
https://doi.org/10.1136/jitc-2022-006121
https://doi.org/10.1136/jitc-2022-006121
Autor:
Tanner M. Johanns, Dale K. Kobayashi, Eric C. Leuthardt, Albert H. Kim, Brian Saunders, Gavin P. Dunn, Joshua W. Osbun, Gregory J. Zipfel, Rupen Desai, Alexandra J. Livingstone, Vivek Durai, Max Schaettler, Connor J. Liu, Nicole M. Kretzer, Bernd H. Zinselmeyer, Michael R. Chicoine, Kenneth M. Murphy, Jay A. Bowman-Kirigin, Anthony Z. Wang
The central nervous system (CNS) antigen presenting cell (APC) which primes anti-tumor CD8+ T cell responses remains undefined. Elsewhere, the conventional dendritic cell 1 (cDC1) performs this role. However, steady-state brain cDC1 are rare; cDC loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb8256bd397b7d60fca7c7827161430
https://doi.org/10.1101/2021.09.13.460088
https://doi.org/10.1101/2021.09.13.460088
Autor:
Maximilian Schaettler, Jay A. Bowman-Kirigin, Alexandra J. Livingstone, Gavin P. Dunn, Christopher A. Miller, Connor J. Liu, Tanner M. Johanns, Dylan T. Blaha, Dale K. Kobayashi, Diane Bender, David M. Kranz
Publikováno v:
Neuro Oncol
Background Although clinical trials testing immunotherapies in glioblastoma (GBM) have yielded mixed results, new strategies targeting tumor-specific somatic coding mutations, termed “neoantigens,” represent promising therapeutic approaches. We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5566a720a1b9e3ad767fcd3834a5de14
https://pubmed.ncbi.nlm.nih.gov/32133512
https://pubmed.ncbi.nlm.nih.gov/32133512